#BEGIN_DRUGCARD DB01720

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C22H16BrNO4

# Chemical_IUPAC_Name:
(2Z)-3-[4-(2-bromophenoxy)phenyl]-2-(phenylformamido)prop-2-enoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid

# HET_ID:
PH7

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C22H16BrNO4/c23-18-8-4-5-9-20(18)28-17-12-10-15(11-13-17)14-19(22(26)27)24-21(25)16-6-2-1-3-7-16/h1-14H,(H,24,25)(H,26,27)/b19-14-

# InChI_Key:
InChIKey=WLPJLQNKCJWAFL-RGEXLXHISA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1720

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
438.271

# Molecular_Weight_Mono:
437.026270652

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1YVF

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
4.72

# Predicted_LogS:
-6.1

# Predicted_Water_Solubility:
3.56e-04 g/l

# Primary_Accession_No:
DB01720

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
657131

# PubChem_Substance_ID:
46508533

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02579

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)C(\NC(=O)C1=CC=CC=C1)=C\C1=CC=C(OC2=CC=CC=C2Br)C=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:25 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Core protein p21:Endoplasmic reticulum
endoplasmic reticulum membrane
single-pass membrane protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D90208

# Drug_Target_1_GenBank_ID_Protein:
221611

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>9033 bp
ATGAGCACAAATCCTAAACCTCAAAGAAAAACCAAACGTAACACCAACCGCCGCCCACAG
GACGTTAAGTTCCCGGGCGGTGGTCAGATCGTTGGTGGAGTTTACCTGTTGCCGCGCAGG
GGCCCCAGGTTGGGTGTGCGCGCGACTAGGAAGACTTCCGAGCGGTCGCAACCTCGTGGA
AGGCGACAACCTATCCCCAAGGCTCGCCGGCCCGAGGGTAGGACCTGGGCTCAGCCCGGG
TACCCTTGGCCCCTCTATGGCAACGAGGGTATGGGGTGGGCAGGATGGCTCCTGTCACCC
CGTGGCTCTCGGCCTAGTTGGGGCCCCACAGACCCCCGGCGTAGGTCGCGTAATTTGGGT
AAGGTCATCGATACCCTTACATGCGGCTTCGCCGACCTCATGGGGTACATTCCGCTTGTC
GGCGCCCCCCTAGGGGGCGCTGCCAGGGCCCTGGCACATGGTGTCCGGGTTCTGGAGGAC
GGCGTGAACTATGCAACAGGGAATCTGCCCGGTTGCTCTTTCTCTATCTTCCTCTTAGCT
TTGCTGTCTTGTTTGACCATCCCAGCTTCCGCTTACGAGGTGCGCAACGTGTCCGGGATA
TACCATGTCACGAACGACTGCTCCAACTCAAGTATTGTGTATGAGGCAGCGGACATGATC
ATGCACACCCCCGGGTGCGTGCCCTGCGTCCGGGAGAGTAATTTCTCCCGTTGCTGGGTA
GCGCTCACTCCCACGCTCGCGGCCAGGAACAGCAGCATCCCCACCACGACAATACGACGC
CACGTCGATTTGCTCGTTGGGGCGGCTGCTCTCTGTTCCGCTATGTACGTTGGGGATCTC
TGCGGATCCGTTTTTCTCGTCTCCCAGCTGTTCACCTTCTCACCTCGCCGGTATGAGACG
GTACAAGATTGCAATTGCTCAATCTATCCCGGCCACGTATCAGGTCACCGCATGGCTTGG
GATATGATGATGAACTGGTCACCTACAACGGCCCTAGTGGTATCGCAGCTACTCCGGATC
CCACAAGCCGTCGTGGACATGGTGGCGGGGGCCCACTGGGGTGTCCTAGCGGGCCTTGCC
TACTATTCCATGGTGGGGAACTGGGCTAAGGTCTTGATTGTGATGCTACTCTTTGCTGGC
GTTGACGGGCACACCCACGTGACAGGGGGAAGGGTAGCCTCCAGCACCCAGAGCCTCGTG
TCCTGGCTCTCACAAGGCCCATCTCAGAAAATCCAACTCGTGAACACCAACGGCAGCTGG
CACATCAACAGGACCGCTCTGAATTGCAATGACTCCCTCCAAACTGGGTTCATTGCTGCG
CTGTTCTACGCACACAGGTTCAACGCGTCCGGGTGCCCAGAGCGCATGGCTAGCTGCCGC
CCCATCGATGAGTTCGCTCAGGGGTGGGGTCCCATCACTCATGATATGCCTGAGAGCTCG
GACCAGAGGCCATATTGCTGGCACTACGCGCCTCGACCGTGCGGGATCGTGCCTGCGTCG
CAGGTGTGTGGTCCAGTGTATTGCTTCACTCCGAGCCCTGTTGTAGTGGGGACGACCGAT
CGTTTCGGCGCTCCTACGTATAGCTGGGGGGAGAATGAGACAGACGTGCTGCTACTTAGC
AACACGCGGCCGCCTCAAGGCAACTGGTTTGGGTGCACGTGGATGAACAGCACTGGGTTC
ACCAAGACGTGCGGGGGCCCTCCGTGCAACATCGGGGGGGTCGGCAACAACACCTTGGTC
TGCCCCACGGATTGCTTCCGGAAGCACCCCGAGGCCACTTACACAAAGTGTGGCTCGGGG
CCCTGGTTGACACCCAGGTGCATGGTTGACTACCCATACAGGCTCTGGCACTACCCCTGC
ACTGTTAACTTTACCGTCTTTAAGGTCAGGATGTATGTGGGGGGCGTGGAGCACAGGCTC
AATGCTGCATGCAATTGGACTCGAGGAGAGCGCTGTGACTTGGAGGACAGGGATAGGTCA
GAACTCAGCCCGCTGCTGCTGTCTACAACAGAGTGGCAGATACTGCCCTGTTCCTTCACC
ACCCTACCGGCCCTGTCCACTGGCTTGATCCATCTTCACCGGAACATCGTGGACGTGCAA
TACCTGTACGGTATAGGGTCGGCAGTTGTCTCCTTTGCAATCAAATGGGAGTATATCCTG
TTGCTTTTCCTTCTTCTGGCGGACGCGCGCGTCTGTGCCTGCTTGTGGATGATGCTGCTG
ATAGCCCAGGCTGAGGCCACCTTAGAGAACCTGGTGGTCCTCAATGCGGCGTCTGTGGCC
GGAGCGCATGGCCTTCTCTCCTTCCTCGTGTTCTTCTGCGCCGCCTGGTACATCAAAGGC
AGGCTGGTCCCTGGGGCGGCATATGCTCTCTATGGCGTATGGCCGTTGCTCCTGCTCTTG
CTGGCCTTACCACCACGAGCTTATGCCATGGACCGAGAGATGGCTGCATCGTGCGGAGGC
GCGGTTTTTGTAGGTCTGGTACTCTTGACCTTGTCACCATACTATAAGGTGTTCCTCGCT
AGGCTCATATGGTGGTTACAATATTTTATCACCAGAGCCGAGGCGCACTTGCAAGTGTGG
GTCCCCCCTCTCAATGTTCGGGGAGGCCGCGATGCCATCATCCTCCTTACATGCGCGGTC
CATCCAGAGCTAATCTTTGACATCACCAAACTCCTGCTCGCCATACTCGGTCCGCTCATG
GTGCTCCAGGCTGGCATAACTAGAGTGCCGTACTTTGTACGCGCTCAGGGGCTCATCCGT
GCATGCATGTTAGTGCGGAAGGTCGCTGGAGGCCACTATGTCCAAATGGCCTTCATGAAG
CTGGCCGCGCTGACAGGTACGTACGTATATGACCATCTTACTCCACTGCGGGATTGGGCC
CACGCGGGCCTACGAGACCTTGCGGTGGCAGTAGAGCCCGTCGTCTTCTCTGACATGGAG
ACTAAACTCATCACCTGGGGGGCAGACACCGCGGCGTGTGGGGACATCATCTCGGGTCTA
CCAGTCTCCGCCCGAAGGGGGAAGGAGATACTTCTAGGACCGGCCGATAGTTTTGGAGAG
CAGGGGTGGCGGCTCCTTGCGCCTATCACGGCCTATTCCCAACAAACGCGGGGCCTGCTT
GGCTGTATCATCACTAGCCTCACAGGTCGGGACAAGAACCAGGTCGATGGGGAGGTTCAG
GTGCTCTCCACCGCAACGCAATCTTTCCTGGCGACCTGCGTCAATGGCGTGTGTTGGACC
GTCTACCATGGTGCCGGCTCGAAGACCCTGGCCGGCCCGAAGGGTCCAATCACCCAAATG
TACACCAATGTAGACCAGGACCTCGTCGGCTGGCCGGCGCCCCCCGGGGCGCGCTCCATG
ACACCGTGCACCTGCGGCAGCTCGGACCTTTACTTGGTCACGAGGCATGCTGATGTCGTT
CCGGTGCGCCGGCGGGGCGACAGCAGGGGGAGCCTGCTTTCCCCCAGGCCCATCTCCTAC
CTGAAGGGCTCCTCGGGTGGACCACTGCTTTGCCCTTCGGGGCACGTTGTAGGCATCTTC
CGGGCTGCTGTGTGCACCCGGGGGGTTGCGAAGGCGGTGGACTTCATACCCGTTGAGTCT
ATGGAAACTACCATGCGGTCTCCGGTCTTCACAGACAACTCATCCCCTCCGGCCGTACCG
CAAACATTCCAAGTGGCACATTTACACGCTCCCACTGGCAGCGGCAAGAGCACCAAAGTG
CCGGCTGCATATGCAGCCCAAGGGTACAAGGTGCTCGTCCTAAACCCGTCCGTTGCCGCC
ACATTGGGCTTTGGAGCGTATATGTCCAAGGCACATGGCATCGAGCCTAACATCAGAACT
GGGGTAAGGACCATCACCACGGGCGGCCCCATCACGTACTCCACCTATTGCAAGTTCCTT
GCCGACGGTGGATGCTCCGGGGGCGCCTATGACATCATAATATGTGATGAATGCCACTCA
ACTGACTCGACTACCATCTTGGGCATCGGCACAGTCCTGGATCAGGCAGAGACGGCTGGA
GCGCGGCTCGTCGTGCTCGCCACCGCCACGCCTCCGGGATCGATCACCGTGCCACACCCC
AACATCGAGGAAGTGGCCCTGTCCAACACTGGAGAGATTCCCTTCTATGGCAAAGCCATC
CCCATTGAGGCCATCAAGGGGGGAAGGCATCTCATCTTCTGCCATTCCAAGAAGAAGTGT
GACGAGCTCGCCGCAAAGCTGACAGGCCTCGGACTCAATGCTGTAGCGTATTACCGGGGT
CTCGATGTGTCCGTCATACCGACTAGCGGAGACGTCGTTGTCGTGGCAACAGACGCTCTA
ATGACGGGTTTTACCGGCGACTTTGACTCAGTGATCGACTGCAACACATGTGTCACCCAG
ACAGTCGATTTCAGCTTGGATCCCACCTTCACCATTGAGACGACAACGCTGCCCCAAGAC
GCGGTGTCGCGTGCGCAGCGGCGAGGTAGGACTGGCAGGGGCAGGAGTGGCATCTACAGG
TTTGTGACTCCAGGAGAACGGCCCTCAGGCATGTTCGACTCCTCGGTCCTGTGTGAGTGC
TATGACGCAGGCTGCGCTTGGTATGAGCTCACGCCCGCTGAGACCTCGGTTAGGTTGCGG
GCTTACCTAAATACACCAGGGTTGCCCGTCTGCCAGGACCACCTAGAGTTCTGGGAGAGC
GTCTTCACAGGCCTCACCCACATAGATGCCCACTTCTTGTCCCAGACCAAACAGGCAGGA
GACAACCTCCCCTACCTGGTAGCATACCAAGCCACAGTGTGCGCCAGGGCTCAGGCTCCA
CCTCCATCGTGGGACCAAATGTGGAAGTGTCTCATACGGCTAAAGCCCACACTGCATGGG
CCAACGCCCCTGCTGTACAGGCTAGGAGCCGTTCAAAATGAGGTCACTCTCACACACCCC
ATAACCAAATACATCATGGCATGCATGTCGGCTGACCTGGAGGTCGTCACTAGCACCTGG
GTGCTAGTAGGCGGAGTCCTTGCGGCTCTGGCCGCGTACTGCCTGACGACAGGCAGCGTG
GTCATTGTGGGCAGGATCATCTTGTCCGGGAGGCCAGCTGTTATTCCCGACAGGGAAGTC
CTCTACCAGGAGTTCGATGAGATGGAAGAGTGTGCTTCACACCTCCCTTACATCGAGCAA
GGAATGCAGCTCGCCGAGCAATTCAAACAGAAGGCGCTCGGATTGCTGCAAACAGCCACC
AAGCAAGCGGAGGCTGCTGCTCCCGTGGTGGAGTCCAAGTGGCGAGCCCTTGAGGTCTTC
TGGGCGAAACACATGTGGAACTTCATCAGCGGGATACAGTACTTGGCAGGCCTATCCACT
CTGCCTGGAAACCCCGCGATAGCATCATTGATGGCTTTTACAGCCTCTATCACCAGCCCG
CTCACCACCCAAAATACCCTCCTGTTTAACATCTTGGGGGGATGGGTGGCTGCCCAACTC
GCTCCCCCCAGCGCTGCTTCGGCTTTCGTGGGCGCCGGCATTGCCGGTGCGGCCGTTGGC
AGCATAGGTCTCGGGAAGGTACTTGTGGACATTCTGGCGGGCTATGGGGCGGGGGTGGCT
GGCGCACTCGTGGCCTTTAAGGTCATGAGCGGCGAGATGCCCTCCACTGAGGATCTGGTT
AATTTACTCCCTGCCATCCTTTCTCCTGGCGCCCTGGTTGTCGGGGTCGTGTGCGCAGCA
ATACTGCGTCGGCACGTGGGCCCGGGAGAGGGGGCTGTGCAGTGGATGAACCGGCTGATA
GCGTTCGCTTCGCGGGGTAACCACGTCTCCCCCACGCACTATGTGCCCGAGAGCGACGCC
GCGGCGCGTGTTACTCAGATCCTCTCCAGCCTTACCATCACTCAGTTGCTGAAGAGGCTT
CATCAGTGGATTAATGAGGACTGCTCCACGCCTTGTTCCGGCTCGTGGCTAAAGGATGTT
TGGGACTGGATATGCACGGTGTTGAGTGACTTCAAGACTTGGCTCCAGTCCAAGCTCCTG
CCGCGGTTACCGGGACTCCCTTTCCTGTCATGCCAACGCGGGTACAAGGGAGTCTGGCGG
GGGGATGGCATCATGCAAACCACCTGCCCATGTGGAGCACAGATCACCGGACATGTCAAA
AATGGCTCCATGAGGATTGTTGGGCCAAAAACCTGCAGCAACACGTGGCATGGAACATTC
CCCATCAACGCATACACCACGGGCCCCTGCACGCCCTCCCCAGCGCCGAACTATTCCAGG
GCGCTGTGGCGGGTGGCTGCTGAGGAGTACGTGGAGGTTACGCGGGTGGGGGATTTCCAC
TACGTGACGGGCATGACCACTGACAACGTGAAATGCCCATGCCAGGTTCCAGCCCCTGAA
TTTTTCACGGAGGTGGATGGAGTACGGTTGCACAGGTATGCTCCAGTGTGCAAACCTCTC
CTACGAGAGGAGGTCGTATTCCAGGTCGGGCTCAACCAGTACCTGGTCGGGTCACAGCTC
CCATGTGAGCCCGAACCGGATGTGGCAGTGCTCACTTCCATGCTCACCGACCCCTCTCAT
ATTACAGCAGAGACGGCCAAGCGTAGGCTGGCCAGGGGGTCTCCCCCCTCCTTGGCCAGC
TCTTCAGCTAGCCAGTTGTCTGCGCCTTCTTTGAAGGCGACATGTACTACCCATCATGAC
TCCCCGGACGCTGACCTCATCGAGGCCAACCTCCTGTGGCGGCAGGAGATGGGCGGGAAC
ATCACCCGTGTGGAGTCAGAAAATAAGGTGGTAATCCTGGACTCTTTCGATCCGATTCGG
GCGGTGGAGGATGAGAGGGAAATATCCGTCCCGGCGGAGATCCTGCGAAAACCCAGGAAG
TTCCCCCCAGCGTTGCCCATATGGGCACGCCCGGATTACAACCCTCCACTGCTAGAGTCC
TGGAAGGACCCGGACTACGTCCCCCCGGTGGTACACGGGTGCCCTTTGCCATCTACCAAG
GCCCCCCCAATACCACCTCCACGGAGGAAGAGGACGGTTGTCCTGACAGAGTCCACCGTG
TCTTCTGCCTTGGCGGAGCTCGCTACTAAGACCTTTGGCAGCTCCGGGTCGTCGGCCGTT
GACAGCGGCACGGCGACTGGCCCTCCCGATCAGGCCTCCGACGACGGCGACAAAGGATCC
GACGTTGAGTCGTACTCCTCCATGCCCCCCCTCGAGGGAGAGCCAGGGGACCCCGACCTC
AGCGACGGGTCTTGGTCTACCGTGAGCGGGGAAGCTGGTGAGGACGTCGTCTGCTGCTCA
ATGTCCTATACATGGACAGGTGCCTTGATCACGCCATGCGCTGCGGAGGAGAGCAAGTTG
CCCATCAATCCGTTGAGCAACTCTTTGCTGCGTCACCACAGTATGGTCTACTCCACAACA
TCTCGCAGCGCAAGTCTGCGGCAGAAGAAGGTCACCTTTGACAGACTGCAAGTCCTGGAC
GACCACTACCGGGACGTGCTCAAGGAGATGAAGGCGAAGGCGTCCACAGTTAAGGCTAGG
CTTCTATCTATAGAGGAGGCCTGCAAACTGACGCCCCCACATTCGGCCAAATCCAAATTT
GGCTACGGGGCGAAGGACGTCCGGAGCCTATCCAGCAGGGCCGTCAACCACATCCGCTCC
GTGTGGGAGGACTTGCTGGAAGACACTGAAACACCAATTGATACCACCATCATGGCAAAA
AATGAGGTTTTCTGCGTCCAACCAGAGAAAGGAGGCCGCAAGCCAGCTCGCCTTATCGTA
TTCCCAGACCTGGGGGTACGTGTATGCGAGAAGATGGCCCTTTACGACGTGGTCTCCACC
CTTCCTCAGGCCGTGATGGGCCCCTCATACGGATTCCAGTACTCTCCTGGGCAGCGGGTC
GAGTTCCTGGTGAATACCTGGAAATCAAAGAAATGCCCTATGGGCTTCTCATATGACACC
CGCTGCTTTGACTCAACGGTCACTGAGAATGACATCCGTACTGAGGAATCAATTTACCAA
TGTTGTGACTTGGCCCCCGAAGCCAGGCAGGCCATAAGGTCGCTCACAGAGCGGCTTTAT
GTCGGGGGTCCCCTGACTAATTCGAAGGGGCAGAACTGCGGTTATCGCCGGTGCCGCGCA
AGTGGCGTGCTGACGACTAGCTGCGGCAACACCCTCACATGTTACTTGAAGGCCACTGCG
GCCTGTCGAGCTGCAAAGCTCCAGGACTGCACGATGCTCGTGAACGGAGACGACCTTGTC
GTTATCTGTGAGAGTGCGGGAACCCAGGAGGATGCGGCGGCCCTACGAGCCTTCACGGAG
GCTATGACTAGGTATTCCGCCCCCCCCGGGGACCCGCCCCAACCAGAATACGACTTGGAG
CTGATAACGTCATGCTCCTCCAATGTGTCGGTCGCGCACGATGCATCCGGCAAAAGGGTG
TACTACCTCACCCGTGACCCCACCACCCCCCTCGCACGGGCTGCGTGGGAGACAGTTAGA
CACACTCCAGTCAACTCCTGGCTAGGCAATATCATCATGTATGCGCCCACCCTATGGGCG
AGGATGATTCTGATGACTCATTTCTTCTCTATCCTTCTAGCTCAGGAGCAACTTGAAAAA
GCCCTGGATTGTCAGATCTACGGGGCCTGTTACTCCATTGAGCCACTTGACCTACCTCAG
ATCATTGAACGACTCCATGGTCTTAGCGCATTTTCACTCCACAGTTACTCTCCAGGTGAG
ATCAATAGGGTGGCTTCATGCCTCAGGAAACTTGGGGTACCGCCTTTGCGAGTCTGGAGA
CATCGGGCCAGAAGTGTCCGCGCTAAGCTACTGTCCCAGGGGGGGAGGGCTGCCACTTGC
GGCAAGTACCTCTTCAACTGGGCAGTAAAGACCAAGCTTAAACTCACTCCAATCCCGGCT
GCGTCCCAGCTAGACTTGTCCGGCTGGTTCGTTGCTGGTTACAACGGGGGAGACATATAT
CACAGCCTGTCTCGTGCCCGACCCCGTTGGTTCATGTTGTGCCTACTCCTACTTTCTGTA
GGGGTAGGCATCTACCTGCTCCCCAACCGGTGA

# Drug_Target_1_General_Function:
Involved in structural molecule activity

# Drug_Target_1_General_References:
10702283	Di Marco S, Rizzi M, Volpari C, Walsh MA, Narjes F, Colarusso S, De Francesco R, Matassa VG, Sollazzo M: Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes. J Biol Chem. 2000 Mar 10;275(10):7152-7.
12560074	Griffin SD, Beales LP, Clarke DS, Worsfold O, Evans SD, Jaeger J, Harris MP, Rowlands DJ: The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett. 2003 Jan 30;535(1-3):34-8.
1849488	Kato N, Hijikata M, Nakagawa M, Ootsuyama Y, Muraiso K, Ohkoshi S, Shimotohno K: Molecular structure of the Japanese hepatitis C viral genome. FEBS Lett. 1991 Mar 25;280(2):325-8.
2175903	Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K: Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9524-8.
7999043	Kaneko T, Tanji Y, Satoh S, Hijikata M, Asabe S, Kimura K, Shimotohno K: Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun. 1994 Nov 30;205(1):320-6.
8392606	Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K, Shimotohno K: Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol. 1993 Aug;67(8):4665-75.
8531962	Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C: Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 1996 Jan 11;334(2):77-81.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2297

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
327024

# Drug_Target_1_Name:
Genome polyprotein

# Drug_Target_1_Number_of_Residues:
3010

# Drug_Target_1_PDB_ID:
1CU1

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00271	Helicase_C
PF00998	RdRP_3
PF01001	HCV_NS4b
PF01006	HCV_NS4a
PF01506	HCV_NS5a
PF01538	HCV_NS2
PF01539	HCV_env
PF01542	HCV_core
PF01543	HCV_capsid
PF01560	HCV_NS1
PF02907	Peptidase_S29
PF08300	HCV_NS5a_1a
PF08301	HCV_NS5a_1b

# Drug_Target_1_Protein_Sequence:
>Genome polyprotein [Contains: Core protein p21
MSTNPKPQRKTKRNTNRRPQDVKFPGGGQIVGGVYLLPRRGPRLGVRATRKTSERSQPRG
RRQPIPKARRPEGRTWAQPGYPWPLYGNEGMGWAGWLLSPRGSRPSWGPTDPRRRSRNLG
KVIDTLTCGFADLMGYIPLVGAPLGGAARALAHGVRVLEDGVNYATGNLPGCSFSIFLLA
LLSCLTIPASAYEVRNVSGIYHVTNDCSNSSIVYEAADMIMHTPGCVPCVRESNFSRCWV
ALTPTLAARNSSIPTTTIRRHVDLLVGAAALCSAMYVGDLCGSVFLVSQLFTFSPRRYET
VQDCNCSIYPGHVSGHRMAWDMMMNWSPTTALVVSQLLRIPQAVVDMVAGAHWGVLAGLA
YYSMVGNWAKVLIVMLLFAGVDGHTHVTGGRVASSTQSLVSWLSQGPSQKIQLVNTNGSW
HINRTALNCNDSLQTGFIAALFYAHRFNASGCPERMASCRPIDEFAQGWGPITHDMPESS
DQRPYCWHYAPRPCGIVPASQVCGPVYCFTPSPVVVGTTDRFGAPTYSWGENETDVLLLS
NTRPPQGNWFGCTWMNSTGFTKTCGGPPCNIGGVGNNTLVCPTDCFRKHPEATYTKCGSG
PWLTPRCMVDYPYRLWHYPCTVNFTVFKVRMYVGGVEHRLNAACNWTRGERCDLEDRDRS
ELSPLLLSTTEWQILPCSFTTLPALSTGLIHLHRNIVDVQYLYGIGSAVVSFAIKWEYIL
LLFLLLADARVCACLWMMLLIAQAEATLENLVVLNAASVAGAHGLLSFLVFFCAAWYIKG
RLVPGAAYALYGVWPLLLLLLALPPRAYAMDREMAASCGGAVFVGLVLLTLSPYYKVFLA
RLIWWLQYFITRAEAHLQVWVPPLNVRGGRDAIILLTCAVHPELIFDITKLLLAILGPLM
VLQAGITRVPYFVRAQGLIRACMLVRKVAGGHYVQMAFMKLAALTGTYVYDHLTPLRDWA
HAGLRDLAVAVEPVVFSDMETKLITWGADTAACGDIISGLPVSARRGKEILLGPADSFGE
QGWRLLAPITAYSQQTRGLLGCIITSLTGRDKNQVDGEVQVLSTATQSFLATCVNGVCWT
VYHGAGSKTLAGPKGPITQMYTNVDQDLVGWPAPPGARSMTPCTCGSSDLYLVTRHADVV
PVRRRGDSRGSLLSPRPISYLKGSSGGPLLCPSGHVVGIFRAAVCTRGVAKAVDFIPVES
METTMRSPVFTDNSSPPAVPQTFQVAHLHAPTGSGKSTKVPAAYAAQGYKVLVLNPSVAA
TLGFGAYMSKAHGIEPNIRTGVRTITTGGPITYSTYCKFLADGGCSGGAYDIIICDECHS
TDSTTILGIGTVLDQAETAGARLVVLATATPPGSITVPHPNIEEVALSNTGEIPFYGKAI
PIEAIKGGRHLIFCHSKKKCDELAAKLTGLGLNAVAYYRGLDVSVIPTSGDVVVVATDAL
MTGFTGDFDSVIDCNTCVTQTVDFSLDPTFTIETTTLPQDAVSRAQRRGRTGRGRSGIYR
FVTPGERPSGMFDSSVLCECYDAGCAWYELTPAETSVRLRAYLNTPGLPVCQDHLEFWES
VFTGLTHIDAHFLSQTKQAGDNLPYLVAYQATVCARAQAPPPSWDQMWKCLIRLKPTLHG
PTPLLYRLGAVQNEVTLTHPITKYIMACMSADLEVVTSTWVLVGGVLAALAAYCLTTGSV
VIVGRIILSGRPAVIPDREVLYQEFDEMEECASHLPYIEQGMQLAEQFKQKALGLLQTAT
KQAEAAAPVVESKWRALEVFWAKHMWNFISGIQYLAGLSTLPGNPAIASLMAFTASITSP
LTTQNTLLFNILGGWVAAQLAPPSAASAFVGAGIAGAAVGSIGLGKVLVDILAGYGAGVA
GALVAFKVMSGEMPSTEDLVNLLPAILSPGALVVGVVCAAILRRHVGPGEGAVQWMNRLI
AFASRGNHVSPTHYVPESDAAARVTQILSSLTITQLLKRLHQWINEDCSTPCSGSWLKDV
WDWICTVLSDFKTWLQSKLLPRLPGLPFLSCQRGYKGVWRGDGIMQTTCPCGAQITGHVK
NGSMRIVGPKTCSNTWHGTFPINAYTTGPCTPSPAPNYSRALWRVAAEEYVEVTRVGDFH
YVTGMTTDNVKCPCQVPAPEFFTEVDGVRLHRYAPVCKPLLREEVVFQVGLNQYLVGSQL
PCEPEPDVAVLTSMLTDPSHITAETAKRRLARGSPPSLASSSASQLSAPSLKATCTTHHD
SPDADLIEANLLWRQEMGGNITRVESENKVVILDSFDPIRAVEDEREISVPAEILRKPRK
FPPALPIWARPDYNPPLLESWKDPDYVPPVVHGCPLPSTKAPPIPPPRRKRTVVLTESTV
SSALAELATKTFGSSGSSAVDSGTATGPPDQASDDGDKGSDVESYSSMPPLEGEPGDPDL
SDGSWSTVSGEAGEDVVCCSMSYTWTGALITPCAAEESKLPINPLSNSLLRHHSMVYSTT
SRSASLRQKKVTFDRLQVLDDHYRDVLKEMKAKASTVKARLLSIEEACKLTPPHSAKSKF
GYGAKDVRSLSSRAVNHIRSVWEDLLEDTETPIDTTIMAKNEVFCVQPEKGGRKPARLIV
FPDLGVRVCEKMALYDVVSTLPQAVMGPSYGFQYSPGQRVEFLVNTWKSKKCPMGFSYDT
RCFDSTVTENDIRTEESIYQCCDLAPEARQAIRSLTERLYVGGPLTNSKGQNCGYRRCRA
SGVLTTSCGNTLTCYLKATAACRAAKLQDCTMLVNGDDLVVICESAGTQEDAAALRAFTE
AMTRYSAPPGDPPQPEYDLELITSCSSNVSVAHDASGKRVYYLTRDPTTPLARAAWETVR
HTPVNSWLGNIIMYAPTLWARMILMTHFFSILLAQEQLEKALDCQIYGACYSIEPLDLPQ
IIERLHGLSAFSLHSYSPGEINRVASCLRKLGVPPLRVWRHRARSVRAKLLSQGGRAATC
GKYLFNWAVKTKLKLTPIPAASQLDLSGWFVAGYNGGDIYHSLSRARPRWFMLCLLLLSV
GVGIYLLPNR

# Drug_Target_1_Reaction:
nucleoside triphosphate + RNAn = diphosphate + RNAn+1

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
NS5B is a RNA-dependent RNA polymerase that plays an essential role in the virus replication

# Drug_Target_1_SwissProt_ID:
P26662

# Drug_Target_1_SwissProt_Name:
POLG_HCVJA

# Drug_Target_1_Synonyms:
Capsid protein C
Core protein p19
EC 2.7.7.48
EC 3.4.21.98
EC 3.4.22.-
EC 3.6.1.-
EC 3.6.1.15
Envelope glycoprotein E1
Envelope glycoprotein E2
Genome polyprotein [Contains: Core protein p21
Hepacivirin
NS1
NS3P
NS4A
NS4B
NS5A
NS5B
Non-structural protein 4A
Non-structural protein 4B
Non-structural protein 5A
Protease NS2-3
RNA-directed RNA polymerase
Serine protease/NTPase/helicase NS3
gp32
gp35
gp68
gp70
p21
p23
p27
p56
p68]
p7
p70
p8

# Drug_Target_1_Theoretical_pI:
8.07

# Drug_Target_1_Transmembrane_Regions:
169-189
359-379
726-746
758-778
783-803
814-834
882-902
929-949
1658-1678
1806-1826
1829-1849
1851-1871
1882-1902
2990-3010

#END_DRUGCARD DB01720
